- Home
- MYFW vs ABOS Comparison
MYFW vs ABOS Comparison
Compare MYFW & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYFW
- ABOS
- Stock Information
- Founded
- MYFW 2002
- ABOS 1996
- Country
- MYFW United States
- ABOS United States
- Employees
- MYFW N/A
- ABOS N/A
- Industry
- MYFW Major Banks
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- MYFW Finance
- ABOS Health Care
- Exchange
- MYFW Nasdaq
- ABOS Nasdaq
- Market Cap
- MYFW 201.1M
- ABOS 72.7M
- IPO Year
- MYFW 2018
- ABOS 2021
- Fundamental
- Price
- MYFW $22.60
- ABOS $1.18
- Analyst Decision
- MYFW Buy
- ABOS Strong Buy
- Analyst Count
- MYFW 2
- ABOS 4
- Target Price
- MYFW $24.25
- ABOS $6.50
- AVG Volume (30 Days)
- MYFW 48.8K
- ABOS 571.8K
- Earning Date
- MYFW 07-22-2025
- ABOS 08-12-2025
- Dividend Yield
- MYFW N/A
- ABOS N/A
- EPS Growth
- MYFW 154.12
- ABOS N/A
- EPS
- MYFW 1.04
- ABOS N/A
- Revenue
- MYFW $91,514,000.00
- ABOS N/A
- Revenue This Year
- MYFW $17.24
- ABOS N/A
- Revenue Next Year
- MYFW $10.85
- ABOS N/A
- P/E Ratio
- MYFW $21.76
- ABOS N/A
- Revenue Growth
- MYFW 13.99
- ABOS N/A
- 52 Week Low
- MYFW $15.54
- ABOS $0.86
- 52 Week High
- MYFW $23.71
- ABOS $3.60
- Technical
- Relative Strength Index (RSI)
- MYFW 64.89
- ABOS 56.83
- Support Level
- MYFW $21.72
- ABOS $1.05
- Resistance Level
- MYFW $22.55
- ABOS $1.28
- Average True Range (ATR)
- MYFW 0.63
- ABOS 0.09
- MACD
- MYFW 0.16
- ABOS 0.01
- Stochastic Oscillator
- MYFW 99.74
- ABOS 61.54
About MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.